Jeantet advises the Prologue group in the context of its capital reorganization, which involved a public exchange offer launched by Prologue for the shares of its sub-subsidiary M2i, followed by the merger by prologue of its subsidiary O2i

 

Paris, August 30, 2021, Jeantet advised the Prologue Group, a group specialized in software, IT services and training, digital and management, as part of a project to strengthen the capital of the Group, which is composed of three listed companies: the parent company Prologue, listed on the regulated market of Euronext Paris, its subsidiary O2i and its sub-subsidiary M2i (controlled by O2i), both listed on Euronext Growth Paris.

This global reorganization consisted firstly of a simplified public exchange offer launched by Prologue for the M2i shares according to an exchange ratio of 11 Prologue shares for 1 M2i share tendered (the “Exchange Offer“), which was declared compliant by the French Financial Markets Authority (the “AMF“) on July 6, 2021 and which was open from July 8, 2021 to July 28, 2021. According to the notice of result published by the AMF on July 29, 2021, 3,458,673 M2i shares were tendered to the Exchange Offer, representing 68.67% of the share capital and 63.25% of the voting rights of M2i. 38,045,403 new Prologue shares were thus issued to the benefit of the M2i shareholders who tendered their shares to the Exchange Offer.

In a second step, the merger of O2i into Prologue according to an exchange ratio of 8 Prologue shares for 3 O2i shares (the “Merger“) was completed on August 11, 2021, a few days after the settlement of the Exchange Offer which took place on August 6, 2021. As a result, 26,328,128 new Prologue shares were issued to the benefit of the O2i shareholders.

The tendering of the M2i shares held by O2i to the Exchange Offer led O2i to receive a significant number of Prologue shares as consideration for the contribution. In its decision of July 6, 2021, the AMF authorized O2i to temporarily cross the threshold of 30% of the share capital and voting rights in Prologue, without having to file a mandatory tender offer for the Prologue shares, in accordance with the provisions of articles 234-4 and 234-10 of the General Regulation of the AMF. This crossing lasted only a few days, between the settlement of the Exchange Offer and the effective completion of the Merger leading to the dissolution of O2i.

The Merger was immediately followed by a capital reduction completed on August 12, 2021 through the cancellation of 23,789,946 treasury shares held by Prologue as a result of the Merger (Prologue had indeed received a significant number of its own shares as a result of the transfer of all the O2i assets in the context of the Merger), thus allowing to “relute” all the Prologue shareholders. This “relution” occurred after Prologue transferred a proportion of these treasury shares (i.e. 8,292,874 Prologue shares) into the trust that had been set up in the context of the transaction with O2i in 2015, so that the said trust holds as of today 9.99% of Prologue’s share capital. The transfer of these existing Prologue shares into the trust is intended to allow the implementation of free share allocations to the benefit of all employees of the Prologue Group in the context of future plans, avoiding to create additional dilution for Prologue shareholders in the coming years.

The shareholders of Prologue and O2i had approved the resolutions relating to all these transactions (which were inseparable from each other, so that if one of them could not be carried out, the others would not have been implemented) at the general meetings held on June 30, 2021.

This reorganization enables Prologue to (i) directly hold 100% of the O2i group’s business and thus simplify the legal structure of the group as a whole, and optimize its organization, operation and costs, (ii) offer greater clarity to investors, (iii) limit costs by maintaining the listing of only two companies (Prologue and M2i) instead of three, and (iv) further promote the liquidity of the Prologue shares.

– –

Jeantet: Cyril Deniaud and Frank Martin Laprade, partners, Benjamin Cohu and Claire Coquard, associates (Capital Markets Law), Jean-Guillaume Follorou, partner, and François-Xavier Simeoni, associate (Tax Law), and Laetitia Ternisien, counsel (Employment Law).

Invest Securities acted as presenting bank in the context of the Exchange Offer.

Mr. Olivier Péronnet, from Finexsi, had been appointed as sole appraiser for the contributions and the merger (within the framework of the Exchange Offer and the Merger).

Associés en Finance, represented by Mr. Philippe Leroy, had been appointed as independent expert by the Board of Directors of M2i in the framework of the Exchange Offer.

Our last press releases

Jeantet advises Mercury Engineering on a syndicated financing

Paris, July 2026 – Jeantet acted as French legal counsel to the MERCURY ENGINEERING group in connection with EUR 109,462,500 facilities, together with an accordion facility of up to EUR 100,000,000, acceded to by Mercury Engineering France. This financing was granted by a syndicate comprising in particular Allied Irish Banks, p.l.c., Citibank and Barclays, as […]

Paris | BANK-FINANCE-REGULATORY

+

JEANTET ADVISES CRODA INTERNATIONAL PLC ON A MULTICURRENCY NOTE ISSUANCE

Paris, June 2026 – Jeantet acted as French legal counsel to CRODA International PLC and its subsidiary SEDERMA SAS in connection with a multicurrency notes offering to US pension funds in an aggregate amount of £50,000,000 and €100,000,000. CRODA International PLC is one of the world’s leading manufacturers of specialty chemicals for cosmetics and personal […]

Paris | BANKING AND FINANCE LAW

+

JEANTET ADVISED IRIS VENTURES IN ITS STRATEGIC INVESTMENT IN KRÈME

Paris, July 31, 2026 – Jeantet advised Iris Ventures in its strategic investment in Krème, France’s leading dermocosmetics brand pioneering microbiome-powered skincare, fueling its next phase of growth. Founded in 2020 by Juliette Lailler and Marie Belile, Krème pioneers microbiome-based skincare for sensitive skin, combining probiotic ferments with pharmaceutical rigor in natural, high-tolerance formulas made […]

Paris

+

Jeantet advised Nexum Pharma on the acquisition of the assets of Livmed’s

Paris, July 22, 2026 – Jeantet advised Nexum Pharma on the acquisition of the assets of Livmed’s as part of the judicial liquidation proceedings before the Nice Commercial Court. Nexum Pharma is a French healthtech company specializing in the home delivery of pharmacy and parapharmacy products. Through this acquisition, Nexum Pharma strengthens its technological capabilities […]

Paris | Corporate / M&A / Private Equity

+

Jeantet advised Tevalia Capital in the conclusion of a strategic partnership with Alba Infra Partners

Paris, 20 July 2026 – Jeantet advised Tevalia Capital in the framework of the launch with Alba Infra Partners of Altevera, a pan-European renewable developer and energy generation platform. Alba Infra Partners, through its EOPF II fund, and Tevalia Capital have launched Altevera, a pan-European platform for the development and generation of renewable energy, focusing […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises the CPM group on acquisition financing granted by funds managed by Muzinich Co

Paris, July, 2026 – Jeantet acted as French legal counsel to CORPPERFORMANCE BIDCO AG, a Swiss company, as borrower, in connection with a Swiss law governed acquisition financing in an aggregate amount of EUR 45,000,000 to which CPM Partners SAS has acceded. The financing consists of a non-amortising acquisition/capex facility and a bridge credit facility, […]

| BANKING AND FINANCE LAW

+

Jeantet advises RGREEN INVEST on a €52.4 million investment in the holding company of the founder of Arverne Group

Paris, July 10, 2026 – Jeantet advised RGREEN INVEST on a €52.4 million investment in the holding company of the founder of Arverne Group, a company listed on the regulated market of Euronext Paris. RGREEN INVEST and Pierre Brossollet, founder and CEO of Arverne, a leading French provider of geothermal solutions listed on the regulated […]

| CAPITAL MARKETS AND STOCK EXCHANGE LAW | TAX

+

Jeantet advises Apollo Minerals Limited in the context of its listing on Euronext Growth Paris

Paris, 6 July, 2026 – Jeantet advised Apollo Minerals Limited, an Australian company specialized in the mineral exploration and development sector operating in France, Gabon and Serbia, on its listing on Euronext Growth Paris by way of direct admission, resulting in a market capitalization of circa €42 million. Apollo Minerals Limited is based in Perth, […]

Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW | LISTED COMPANIES AND CAPITAL MARKETS LAW

+

Jeantet advises Hoffmann Green Cement Technologies on its share capital increase by way of private placement intended for qualified investors

Paris, June 29, 2026 – Jeantet has advised Hoffmann Green Cement Technologies, a company listed on Euronext Growth Paris, on its share capital increase by way of private placement intended for qualified investors. The share capital increase involved the issuance of a total of 1,271,485 shares, representing a total share capital increase of circa €5 […]

| CAPITAL MARKETS AND STOCK EXCHANGE LAW

+

Jeantet advises Media 6 and its controlling shareholder Vasco in connection with the public buy-out offer followed by a squeeze-out on Media 6 shares launched by Vasco

Paris, June 30, 2026 – Jeantet advised MEDIA 6, a company specialized in the design and merchandising of physical retail locations for major luxury brands across the Asia-Pacific, Europe, and North America regions, in connection with the public buy-out offer on its shares, launched by its controlling shareholder Vasco (acting in concert with the Vasseur […]

Paris | LISTED COMPANIES AND CAPITAL MARKETS LAW

+

JEANTET HAS ADVISED EMMI AI’S SHAREHOLDERS IN CONNECTION WITH ITS ACQUISITION BY MISTRAL AI

Paris, May 19, 2026 – Jeantet advised the shareholders of Emmi AI alongside the Austrian law firms Dorda and Schönherr, in connection with the acquisition by Mistral AI of the entire share capital of Emmi AI. This merger aims to combine Mistral AI’s leading AI systems with Emmi AI’s unique expertise in AI applied to […]

| CORPORATE – M&A – PRIVATE EQUITY | TAX LAW

+

Jeantet announces the promotion of six new Counsels

Paris, May 12, 2026 – Jeantet is pleased to announce the promotion of six new Counsels: Perrine Fuchs (Corporate M&A), Juliette Hubert (Employment Law), Maria Plakci (M&A, Private Equity), Georges-Dominic Sardi (M&A, Venture Capital), Jessica Sellem (Tax Law) and Hugues Vaysset (Banking and Finance Law).  “These promotions reflect the excellence, commitment, and professionalism of Perrine, […]

+